Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial/ethnic and geographic differences in second primary cancers in stomach cancer survivors: a comparative study of U.S. and South Korea.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

An Observational Cohort Study on Non-Recurrence Procedural Intervention and Reoperation for Recurrence After Ventral Hernia Repair.

Annals of surgery·2026
Same author

Association of Sex With the Use and Outcomes of Carotid Revascularization: A Cohort Study.

Stroke (Hoboken, N.J.)·2026
Same author

Postmarket Surveillance of Neuroendovascular Devices.

Stroke (Hoboken, N.J.)·2026
Same author

From use cases to infrastructure: a cross-institutional survey of priorities in data-driven biomedical research.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Antibiotic-Loaded Bone Cement and Risk of Infection After Knee Arthroplasty in High-Risk Patients: A Register Based Meta-Analysis.

JB & JS open access·2025

Related Experiment Video

Updated: May 20, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Long-term outcomes after transmyocardial revascularization.

Dale R Tavris1, James Matthew Brennan, Art Sedrakyan

  • 1US Food and Drug Administration, Center for Devices and Radiological Health, Division of Epidemiology, Silver Spring, MD 20993, USA. dale.tavris@fda.hhs.gov

The Annals of Thoracic Surgery
|July 28, 2012
PubMed
Summary

Transmyocardial revascularization (TMR) combined with coronary artery bypass graft (CABG) surgery is increasing. While some short-term differences exist between TMR devices, long-term outcomes show no significant variations.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Experiment Videos

Last Updated: May 20, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Procedures
  • Medical Device Technology

Background:

  • Reports indicate higher operative mortality for transmyocardial revascularization (TMR) than initially suggested.
  • This study investigates temporal trends and outcomes of TMR, comparing isolated procedures with those combined with coronary artery bypass graft (CABG).

Purpose of the Study:

  • To assess temporal trends in TMR utilization.
  • To evaluate short-term and long-term patient outcomes associated with TMR.
  • To compare outcomes between two distinct TMR devices and procedural types (TMR alone vs. TMR + CABG).

Main Methods:

  • Analysis of 15,386 patients undergoing TMR from January 2000 to November 2006, utilizing the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
  • Long-term outcomes were assessed by linking to Medicare claims data.
  • Comparison of short-term and 7-year adverse outcomes between two TMR devices: holmium:YAG laser and Heart Laser CO2.

Main Results:

  • Transmyocardial revascularization (TMR) use in conjunction with coronary artery bypass graft (CABG) surgery is on the rise.
  • The holmium:YAG laser TMR device showed a higher operative mortality rate (3.5%) compared to the Heart Laser CO2 system (2.5%) when used with CABG, though composite short-term morbidity/mortality did not differ significantly.
  • No clinically meaningful differences in long-term outcomes were observed between the two TMR devices.

Conclusions:

  • Modest short-term differences in morbidity and mortality between the two TMR devices warrant further investigation.
  • The study highlights the evolving use of TMR in cardiac surgery and the importance of device-specific outcome analysis.